Skip to main content

Table 1 Relationship between miR-34a expression and clinicopathological features in EHCC patients

From: microRNA-34a inhibits epithelial mesenchymal transition in human cholangiocarcinoma by targeting Smad4 through transforming growth factor-beta/Smad pathway

Clinicopathological features n miR-34a P value
Low High
Age (yr)     0.695
<60 14 4 10  
≥60 13 5 8  
Gender     1.000
Male 16 8 8  
Female 11 6 5  
Tumor size (cm)     0.449
<2 12 5 7  
≥2 15 9 6  
Pathological type     0.222
Adenocarcinoma 24 11 13  
Mucocellulare carcinoma 0 0 0  
Adenosquamous carcinoma 3 3 0  
Squamous carcinoma 0 0 0  
Undifferentiated carcinoma 0 0 0  
Cell differentiation     0.326
Well 4 3 1  
Moderately 8 5 3  
Poorly 15 8 7  
Bismuth classification     0.385
Bismuth I 7 1 6  
Bismuth II 13 10 3  
Bismuth III 6 2 4  
Bismuth IV 1 1 0  
Lymphatic node metastasis     0.004
Absent 9 1 8  
Present 18 13 5  
Clinical stages     <0.001
I + II 13 2 11  
III + IV 14 12 2  
  1. P <0.05 is significant